# Identification and Treatment of Thrombotic Microangiopathies in Allogeneic Stem Cell Transplants

> **NCT02604420** · — · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 200 (actual)

## Conditions studied

- Thrombotic Microangiopathy
- Disorder Related to Bone Marrow Transplantation

## Interventions

- **DRUG:** eculizumab

## Key facts

- **NCT ID:** NCT02604420
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2018-03-28
- **Final completion:** 2018-03-28
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2018-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02604420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02604420, "Identification and Treatment of Thrombotic Microangiopathies in Allogeneic Stem Cell Transplants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02604420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*